Scholar, Visiting (EXT)
Center for Life Sciences, 5th Floor
3 Blackfan Circle
Boston MA 02115
Neal I. Muni, MD, MSPH, is the Founder and Managing Director of RTK Group, LLC, a biopharmaceutical advisory and investment practice focused on supporting clinical-stage therapeutics from development to commercialization.
Prior to founding RTK Group, Dr. Muni served for over 20 years in senior roles across the entire life sciences value chain, most recently serving as the CEO of Azurity Pharmaceuticals (formerly CutisPharma). In his role, Dr. Muni led two successful private equity transactions, including a recapitalization with Ampersand Capital Partners and successful company sale and exit to Novaquest Capital Management. During his tenure, Dr. Muni led the transformation of CutisPharma from pharmacy distribution into a fully-integrated specialty pharma, leading the acquisition of Silvergate Pharmaceuticals as well as overseeing the FDA approval and launch of two pipeline drugs, FIRVANQ® for clostridium dificile colitis and Katerzia® for pediatric hypertension.
Prior to CutisPharma, Dr. Muni served as the Head of New Product Planning and Corporate Strategy at Sunovion Pharmaceuticals, leading portfolio strategy and supporting corporate M&A and licensing. Prior to that, Dr. Muni was an engagement manager at the healthcare investment bank Leerink Swann (now SVB Leerink). Prior to Leerink, he was a Medical Officer in the Division of Cardiovascular Devices at the FDA, serving as the lead medical reviewer for drug-eluting intracoronary stents.
Over the past 20 years, Dr. Muni has maintained staff appointments at Harvard Medical School and its teaching hospitals, including Brigham and Women’s Hospital, Dana Farber Cancer Institute, and Faulkner Hospital. Dr. Muni is currently appointed as a Visiting Scholar at Harvard Medical School’s Wyss Institute, mentoring project teams and collaborating on technology development, partnering, and company formation. Dr. Muni completed his residency in Internal Medicine at the Brigham and is appointed as Associate Physician on the hospitalist service, supervising medical residents and students. Dr. Muni received his MD as well as Master of Science in Public Health (biostatistics) from the Tulane University School of Medicine, and a BA in Business Economics and B.Sc. in Biochemistry from Brown University.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.